KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsR&D In ProcessShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Other Gross PP&E Adjustments (2016 - 2024)

Historic Other Gross PP&E Adjustments for Pfizer (PFE) over the last 16 years, with Q4 2024 value amounting to $32.6 billion.

  • Pfizer's Other Gross PP&E Adjustments rose 164.06% to $32.6 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $32.6 billion, marking a year-over-year increase of 164.06%. This contributed to the annual value of $32.6 billion for FY2024, which is 164.06% up from last year.
  • According to the latest figures from Q4 2024, Pfizer's Other Gross PP&E Adjustments is $32.6 billion, which was up 164.06% from $32.1 billion recorded in Q4 2023.
  • Over the past 5 years, Pfizer's Other Gross PP&E Adjustments peaked at $32.6 billion during Q4 2024, and registered a low of $27.0 billion during Q4 2020.
  • Over the past 5 years, Pfizer's median Other Gross PP&E Adjustments value was $28.4 billion (recorded in 2022), while the average stood at $29.4 billion.
  • In the last 5 years, Pfizer's Other Gross PP&E Adjustments skyrocketed by 35.53% in 2021 and then skyrocketed by 1270.83% in 2023.
  • Quarter analysis of 5 years shows Pfizer's Other Gross PP&E Adjustments stood at $27.0 billion in 2020, then rose by 0.36% to $27.1 billion in 2021, then rose by 4.9% to $28.4 billion in 2022, then grew by 12.71% to $32.1 billion in 2023, then increased by 1.64% to $32.6 billion in 2024.
  • Its last three reported values are $32.6 billion in Q4 2024, $32.1 billion for Q4 2023, and $28.4 billion during Q4 2022.